Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

NCT04084314 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT04084314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2019
Completion date
March 13, 2023
Enrollment
701 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine disorders, migraine headache